| Income statement (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.89B | 2.77B | 2.87B | 2.51B | 2.44B | 2.25B | 2.41B | 2.04B |
| Cost of revenue | 931.90M | 940.30M | 961.90M | 842.70M | 822.10M | 795.70M | 771.30M | 664.20M |
| Gross profit | 1.96B | 1.83B | 1.90B | 1.66B | 1.62B | 1.46B | 1.64B | 1.37B |
| Research and development | 370.60M | 361.90M | 352.90M | 329.40M | 313.30M | 316.20M | 294.70M | 286.00M |
| Selling, general and admin | 617.90M | 613.30M | 687.10M | 573.30M | 561.20M | 563.40M | 612.60M | 510.60M |
| Operating expenses | 988.50M | 975.20M | 1.04B | 902.70M | 874.50M | 879.60M | 907.30M | 796.60M |
| Operating income | 971.90M | 855.30M | 864.30M | 759.70M | 743.40M | 578.10M | 734.90M | 577.30M |
| Income before tax | 1.05B | 940.40M | 955.60M | 855.20M | 832.10M | 668.50M | 809.80M | 671.00M |
| Income tax | 231.40M | 114.40M | 156.10M | 146.00M | 167.90M | -35.20M | 121.80M | 100.40M |
| Net income | 818.10M | 821.50M | 794.80M | 704.40M | 658.40M | 698.40M | 685.70M | 565.10M |
| EPS | 2.31 | 2.31 | 2.23 | 1.98 | 1.84 | 1.95 | 1.93 | 1.59 |
| EPS (diluted) | 2.29 | 2.28 | 2.20 | 1.95 | 1.81 | 1.92 | 1.89 | 1.56 |
| Diluted shares | 357.30M | 359.80M | -800.0K | 361.80M | 364.10M | 364.60M | 600.0K | 362.70M |
From Intuitive Surgical's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.